Biodesix (BDSX) Equity Average: 2020-2025
Historic Equity Average for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to -$292,000.
- Biodesix's Equity Average fell 100.91% to -$292,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$292,000, marking a year-over-year decrease of 100.91%. This contributed to the annual value of $12.7 million for FY2024, which is 1.07% up from last year.
- Biodesix's Equity Average amounted to -$292,000 in Q3 2025, which was down 104.79% from $6.1 million recorded in Q2 2025.
- In the past 5 years, Biodesix's Equity Average registered a high of $38.8 million during Q1 2021, and its lowest value of -$4.2 million during Q3 2023.
- Its 3-year average for Equity Average is $9.3 million, with a median of $6.1 million in 2025.
- As far as peak fluctuations go, Biodesix's Equity Average slumped by 276.99% in 2023, and later spiked by 3,563.77% in 2025.
- Over the past 5 years, Biodesix's Equity Average (Quarterly) stood at $17.9 million in 2021, then crashed by 50.49% to $8.9 million in 2022, then plummeted by 82.30% to $1.6 million in 2023, then surged by 1,454.98% to $24.4 million in 2024, then crashed by 100.91% to -$292,000 in 2025.
- Its last three reported values are -$292,000 in Q3 2025, $6.1 million for Q2 2025, and $16.0 million during Q1 2025.